axonicsmodulation.com
Clinical Advisors - Axonics
http://www.axonicsmodulation.com/about/clinical-advisors
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. Timothy Deer, M.D., West Virginia University School of Medicine. Clinical Professor of Anesthesiology. President and Chief Executive Officer The Center for Pain Relief. Karen Noblett, M.D., UC Riverside School of Medicine. Clinical Professor of Obstetrics and Gynecology. Founding Chair of the OB.GYN Department of UCR. The Axonics SNM System is not available in the United States. Scenario Premium Wordpress Theme.
axonicsmodulation.com
Newsroom - Axonics
http://www.axonicsmodulation.com/news
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. Axonics Sacral Neuromodulation System Receives MRI Conditional Labeling. July 28, 2016. European Approval Granted for 1.5T and 3T MRI Scans. Irvine, CA, July 28, 2016. Axonics Modulation Technologies, Inc., developer of the first rechargeable implantable Sacral Neuromodulation (SNM) System for the treatment of urinary and fecal dysfunction. Are now able to safely undergo head and neck MRI scans in 1.5 Tesla and 3 Tesla environments. Company...
axonicsmodulation.com
Overactive Bladder & Fecal Incontinence - Axonics
http://www.axonicsmodulation.com/oab
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. Overactive Bladder & Fecal Incontinence. Overactive Bladder & Fecal Incontinence. Overactive Bladder & Fecal Incontinence. The Axonics SNM System. Millions of people around the world suffer from urinary and fecal dysfunctions. These conditions have been historically under recognized and significantly underserved by the medical community. Overactive Bladder and Fecal Incontinence symptoms can have a significant negative impact on a person’s ...
axonicsmodulation.com
About Us - Axonics
http://www.axonicsmodulation.com/about
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. About Axonics Modulation Technologies. Axonics Modulation Technologies, Inc is a privately-held medical device company developing an innovative neuromodulation platform based on miniaturized rechargeable technology. The Axonics Sacral Neuromodulation System is the first CE-marked rechargeable SNM system designed to improve the experience of both clinicians and patients suffering from Urinary and Fecal dysfunction.
axonicsmodulation.com
The Axonics SNM System - Axonics
http://www.axonicsmodulation.com/product
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. The Axonics SNM System. The Axonics SNM System. Overactive Bladder & Fecal Incontinence. The Axonics SNM System. First rechargeable miniaturized system dedicated to Sacral Neuromodulation. Implantable Pulse Generator (IPG). Designed to prevent migration. Stimulation adjusts for scar tissue formation. Transcutaneous and wireless, allowing patient mobility. Charging takes 2 hours every 1 to 3 weeks. Designed to prevent overheat.
axonicsmodulation.com
Management Team - Axonics
http://www.axonicsmodulation.com/about/management-team
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. Raymond W. Cohen, Chief Executive Officer. Raymond W. Cohen. Dan L Dearen, Chief Operating and Financial Officer. Chief Operating and Financial Officer. Prabodh Mathur, Chief Product Development Officer. Chief Product Development Officer. Guangqiang (Jay) Jiang, Ph.D., Chief Technology Officer. Guangqiang (Jay) Jiang, Ph.D. Michael V. Williamson, Esq., Sr. Vice President, General and IP Counsel. Michael V. Williamson, Esq. Mr Williamson is ...
axonicsmodulation.com
Board of Directors - Axonics
http://www.axonicsmodulation.com/about/board-of-directors
Overactive Bladder & Fecal Incontinence. The Axonics SNM System. Chairman of the Board. Partner at Edmond de Rothschild Investment Partners. Partner at NeoMed Management. Partner at Legend Capital. VP of Research and Development at Alfred Mann Foundation. General Partner at Advent Life Sciences. SVP and General Counsel at Alfred Mann Foundation. Raymond W. Cohen. The Axonics SNM System is CE marked in Europe for the treatment of Overactive Bladder, Fecal Incontinence and Urinary Retention.
